DD300353A5 - Topische formulierungen - Google Patents

Topische formulierungen Download PDF

Info

Publication number
DD300353A5
DD300353A5 DD342542A DD34254290A DD300353A5 DD 300353 A5 DD300353 A5 DD 300353A5 DD 342542 A DD342542 A DD 342542A DD 34254290 A DD34254290 A DD 34254290A DD 300353 A5 DD300353 A5 DD 300353A5
Authority
DD
German Democratic Republic
Prior art keywords
pharmaceutically acceptable
preparation
active ingredient
adhesive layer
pharmaceutical preparations
Prior art date
Application number
DD342542A
Other languages
German (de)
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD300353A5 publication Critical patent/DD300353A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD342542A 1989-07-07 1990-07-05 Topische formulierungen DD300353A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH279589 1989-07-07

Publications (1)

Publication Number Publication Date
DD300353A5 true DD300353A5 (de) 1992-06-04

Family

ID=4241754

Family Applications (1)

Application Number Title Priority Date Filing Date
DD342542A DD300353A5 (de) 1989-07-07 1990-07-05 Topische formulierungen

Country Status (13)

Country Link
EP (1) EP0407345A3 (hu)
JP (1) JPH0344396A (hu)
KR (1) KR910002451A (hu)
AU (1) AU638034B2 (hu)
CA (1) CA2020563A1 (hu)
DD (1) DD300353A5 (hu)
FI (1) FI903328A0 (hu)
HU (1) HU206267B (hu)
IE (1) IE902482A1 (hu)
MX (1) MX21453A (hu)
NZ (1) NZ234378A (hu)
PT (1) PT94610A (hu)
ZA (1) ZA905310B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
KR100732454B1 (ko) * 2001-08-31 2007-06-27 재단법인 포항산업과학연구원 고온 엑스선 실험용 고온장치
US20080182822A1 (en) * 2006-11-17 2008-07-31 Besins Healthcare Sa Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound
EP1923049A1 (en) * 2006-11-17 2008-05-21 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
JP6265967B2 (ja) * 2012-03-14 2018-01-24 ノヴァン，インコーポレイテッド 医薬組成物
US10206947B2 (en) 2013-08-08 2019-02-19 Novan, Inc. Topical compositions and methods of using the same
EP3030266B1 (en) 2013-08-08 2020-10-28 Novan Inc. Topical compositions and methods of using the same
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
GB8618259D0 (en) * 1986-07-25 1986-09-03 Leo Pharm Prod Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
IE902482A1 (en) 1991-02-13
NZ234378A (en) 1992-08-26
CA2020563A1 (en) 1991-01-08
KR910002451A (ko) 1991-02-25
HU206267B (en) 1992-10-28
EP0407345A3 (en) 1991-07-24
JPH0344396A (ja) 1991-02-26
HU904127D0 (en) 1990-12-28
ZA905310B (en) 1991-03-27
AU638034B2 (en) 1993-06-17
AU5870090A (en) 1991-01-10
PT94610A (pt) 1991-03-20
MX21453A (es) 1994-01-31
EP0407345A2 (de) 1991-01-09
HUT54503A (en) 1991-03-28
FI903328A0 (fi) 1990-07-02

Similar Documents

Publication Publication Date Title
DD296418A5 (de) Topisch applizierbare pharmazeutische zubereitungen
EP0285563B1 (de) Transdermale therapeutische Systeme für Wirkstoffkombinationen
AT395526B (de) Mehrfach unterteilte transdermale und dermale pflaster
DE60021099T2 (de) Transdermale, in form einer haftschicht ausgebildete zweifachmedikamenten-verabreichungsvorrichtung
AT397199B (de) Verfahren zur herstellung eines transdermalen therapeutischen membransystems mit diclofenac
EP1827398B1 (de) Transdermales therapeutisches system mit aktivierbarer übersättigung und kontrollierter permeationsförderung
EP0817622B1 (de) Transdermal applizierbares arzneimittel mit ace-hemmern
WO1988001516A1 (en) Transdermal therapeutic system, its use and production process
DE60311449T2 (de) Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen
DE2604718A1 (de) Therapeutische vorrichtung zur verabreichung von skopolaminbase
EP2559427B1 (de) Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
DD300353A5 (de) Topische formulierungen
EP0380989B1 (de) Pflaster zur transdermalen Anwendung
DE3319469C2 (hu)
EP0742716B1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
EP0850052B1 (de) Tacrin/selegilin-pflaster
EP3651744B1 (de) Fampridin-tts
DE102020107937A1 (de) DMEH - Enhancer
DE10317108A1 (de) Transdermal applizierbares Beruhigungs- und Sedierungsmittel
DD279404A5 (de) Flaechenfoermiges, therapeutisches system, verfahren zu seiner herstellung und seine verwendung